Lab Operations Associate Scientist/Scientist I (Contract)
TLDR
Coordinate gene therapy laboratory operations through inventory, equipment maintenance, shipments, safety inspections, and SOP documentation.
Role Summary
We are looking for a talented and highly motivated contract Lab Operations Associate Scientist/Scientist I to join the Lexeo Team in NYC to support the operations within our gene therapy laboratory.
You will be expected to support the daily operations of the laboratory, ensuring that workflows run smoothly, safely, and efficiently. This role reports to the Lab Manager to oversee equipment, procure supplies, manage shipments, and ensure compliance with safety standards. The ideal candidate is organized, detail-oriented, and comfortable balancing administrative responsibilities with hands‑on lab support. The nature of the role will require in-person work 5 days per week.
Primary Responsibilities
The successful candidate will embrace this challenging role with enthusiasm, demonstrate the ability to work within a team, and maintain professionalism while getting things done quickly and efficiently. Attention to detail is expected. The ability to juggle many task at the same time meticulous and detail-oriented approach is crucial for maintaining accuracy.
Required Skills and Qualifications
About Lexeo
Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.
Lexeo Therapeutics is a clinical-stage genetic medicine company focused on pioneering therapies for inherited cardiovascular diseases. Our lead program targets cardiomyopathy linked to Friedreich’s Ataxia, while we also tackle a range of genetically defined conditions, leveraging innovative science to drive impactful clinical solutions.